World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today explained details of fundamental changes being set in motion at the UN agency, including greater impact, increased staff work and training at the country level, producing ‘world class’ work, more transparency, and digital health and innovation. In his opening remarks to the WHO Executive Board, he listed recent accomplishments and devoted significant attention to staffing issues at a time when unconfirmed reports of alleged misconduct have been circulating. Continue reading ->

Image Credits: William New.

First in a two-part series.

Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading ->

Image Credits: MMV/Vivian Zanata, MMV/Damien Schumann.

The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025.

The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here’s what you need to know to follow the action. Continue reading ->

Image Credits: Flickr – Elaine Smith.